The uptick in clinical trials research offers cancer patients with advanced disease new options, including new drugs and new combination therapies.
Benjamin G. Neel, MD, PhD, director of NYU Langone’s Perlmutter Cancer Center, spoke to SurvivorNet about the importance of these clinical trials and what they can do to help patients. Although many drugs tested in trials will fail, there are also greater odds for a successful outcome. “There is an incredible bevy of new therapies being developed,” Dr. Neel says. “If I were a cancer patient with a widely spread metastatic cancer, I would want to be on a clinical trial.”
Read more from SurvivorNet.